International Patent: USE OF CLASS OF POLYPEPTIDES BLOCKING SH2 DOMAIN FOR TUMOR TREATMENT, INFLAMMATION AND IMMUNE DISEASES

GENEVA, Sept. 18 -- THE FIRST AFFILIATED HOSPITAL, ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE (ZHEJIANG PROVINCIAL FIRST HOSPITAL) filed a patent application (CN2026/077258) for “USE OF CLASS OF POLYPEPTIDES BLOCKING SH2 DOMAIN FOR TUMOR TREATMENT, INFLAMMATION AND IMMUNE DISEASES”. With publication no. WO/2026/184363, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 7/08

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....